Author/Creator: Hohenstein, B. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Hohenstein, B.

1. Comparing the efficacy of three techniques to reduce isoagglutinin titers in AB0 incompatible kidney transplant recipients. (November 2017)

Authors:: Parmentier, S.P.; Rosenkranz, E.; Schirutschke, H.; Opgenoorth, M.; Quick, C.; Hoelig, K.; Rosner, A.; Hohenstein, B.; Hugo, C.; Passauer, J.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 253
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Dysregulation of the CD4+ T cells lineage differentiation in dyslipidemic patients and impact of lipoprotein-apheresis treatment: A case study. (November 2017)

Authors:: Papin, J.; Brennand, A.; Arbore, G.; Hohenstein, B.; Kamvissi, V.; Kemper, C.; Bornstein, S.R.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 238
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Effects of different lipoprotein apheresis methods on serum protein levels. (May 2015)

Authors:: Julius, U.; Siegert, G.; Kostka, H.; Schatz, U.; Hohenstein, B.
Journal:: Atherosclerosis
Issue:: Volume 18(2015)
Page Start:: 95
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Effects of Lipoprotein apheresis on the Lipoprotein(a) levels in the long run. (May 2015)

Authors:: Groß, E.; Hohenstein, B.; Julius, U.
Journal:: Atherosclerosis
Issue:: Volume 18(2015)
Page Start:: 226
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Kinetics of Lipoprotein(a) in patients undergoing weekly lipoprotein apheresis for Lp(a) hyperlipoproteinemia. (November 2017)

Authors:: Tselmin, S.; Müller, G.; Schatz, U.; Julius, U.; Bornstein, S.R.; Hohenstein, B.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 209
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Lipoprotein apheresis influences monocyte subpopulations. (November 2017)

Authors:: Jellinghaus, S.; Reich, C.; Schatz, U.; Tselmin, S.; Ibrahim, K.; Pfluecke, C.; Schauer, A.; Bornstein, S.R.; Hohenstein, B.; Strasser, R.H.; Julius, U.; Poitz, D.M.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 108
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Monitoring of complement activation biomarkers and eculizumab in complement‐mediated renal disorders. (25th November 2016)

Authors:: Wehling, C.; Amon, O.; Bommer, M.; Hoppe, B.; Kentouche, K.; Schalk, G.; Weimer, R.; Wiesener, M.; Hohenstein, B.; Tönshoff, B.; Büscher, R.; Fehrenbach, H.; Gök, Ö.‐N.; Kirschfink, M.
Journal:: Clinical and experimental immunology
Issue:: Volume 187:Number 2(2017:Feb.)
Page Start:: 304
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study. (November 2017)

Authors:: Schatz, U.; Tselmin, S.; Müller, G.; Julius, U.; Hohenstein, B.; Fischer, S.; Bornstein, S.R.
Journal:: Atherosclerosis
Issue:: Volume 30(2017)
Page Start:: 246
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. The German Lipoprotein Apheresis Registry (GLAR) – more than 7 years on. (August 2021)

Authors:: Schettler, V.J.J.; Peter, C.; Zimmermann, T.; Julius, U.; Roeseler, E.; Schlieper, G.; Heigl, F.; Grützmacher, P.; Löhlein, I.; Klingel, R.; Hohenstein, B.; Vogt, A.
Journal:: Atherosclerosis
Issue:: Volume 331(2021)
Page Start:: e21
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗